Overview Dividends

(LRCX) Lam Research - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5128073062

Deposition,Etch,Clean,Refurbish,Service

Semiconductor Materials & Equipment
Market Cap in USD: 176,028m

IPO / Inception: 1984-05-11
Return 12m vs S&P 500: 85.9%

EPS (Earnings per Share)

EPS CAGR: -39.95%
EPS Trend: -80.3%

Last SUE: 0.18
Qual. Beats: 0

Revenue

Rev. CAGR: 6.35%
Rev. Trend: 20.1%

Last SUE: 2.36
Qual. Beats: 5

Dividends

Dividend Yield	0.78%
Yield on Cost 5y	2.83%
Yield CAGR 5y	7.44%
Payout Consistency	98.6%
Payout Ratio	21.6%

Risk via 10d forecast
Volatility	47.8%
Value at Risk 5%th	74.7%
Relative Tail Risk	-4.91%

Reward TTM
Sharpe Ratio	1.75
Alpha	88.15
CAGR/Max DD	1.12

Character TTM
Hurst Exponent	0.477
Beta	1.862
Beta Downside	1.792

Drawdowns 3y
Max DD	47.10%
Mean DD	13.11%
Median DD	8.46%

Description: LRCX Lam Research September 24, 2025

Lam Research Corp (NASDAQ:LRCX) designs, manufactures, markets, refurbishes, and services a full suite of semiconductor processing tools used to build integrated circuits worldwide. Its portfolio spans deposition (ALTUS, SABRE, SPEED, Striker, VECTOR), etch (Flex, Vantex, Kiyo, Syndion, Versys), cleaning (Coronus, Da Vinci, DV-Prime, EOS, SP series) and advanced platform solutions (Reliant, Sense.i), supported by service, spares, and upgrades.

Key quantitative signals (FY 2023): revenue of $17.6 billion, up ~13 % YoY, driven by strong demand for advanced-node equipment (3 nm and below) and growth in AI-related workloads. The company’s gross margin held at ~46 %, reflecting pricing power in a concentrated market where Lam commands ~30 % share of the global wafer-fab equipment spend. Capital-expenditure cycles in the semiconductor sector, amplified by the U.S. CHIPS Act and rising fab capacity in Taiwan, South Korea, and the U.S., remain the primary macro driver of Lam’s order backlog.

For a deeper, data-rich evaluation of Lam’s valuation dynamics, you may find ValueRay’s analyst toolkit useful for extending this initial overview.

Piotroski VR‑10 (Strict, 0-10) 9.0

Net Income (5.81b TTM) > 0 and > 6% of Revenue (6% = 1.18b TTM)

FCFTA 0.27 (>2.0%) and ΔFCFTA 1.93pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 41.34% (prev 52.27%; Δ -10.93pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.29 (>3.0%) and CFO 6.38b > Net Income 5.81b (YES >=105%, WARN >=100%)

Net Debt (-2.21b) to EBITDA (7.01b) ratio: -0.32 <= 3.0 (WARN <= 3.5)

Current Ratio 2.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (1.27b) change vs 12m ago -2.66% (target <= -2.0% for YES)

Gross Margin 49.31% (prev 47.47%; Δ 1.85pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 94.57% (prev 79.82%; Δ 14.75pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 49.38 (EBITDA TTM 7.01b / Interest Expense TTM 134.0m) >= 6 (WARN >= 3)

Altman Z'' 11.78

(A) 0.37 = (Total Current Assets 14.81b - Total Current Liabilities 6.71b) / Total Assets 21.90b

(B) 1.38 = Retained Earnings (Balance) 30.23b / Total Assets 21.90b

warn (B) unusual magnitude: 1.38 — check mapping/units

(D) 2.58 = Book Value of Equity 30.16b / Total Liabilities 11.71b

Total Rating: 11.78 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 80.54

1. Piotroski 9.0pt

2. FCF Yield 3.36%

3. FCF Margin 29.85%

4. Debt/Equity 0.44

5. Debt/Ebitda -0.32

6. ROIC - WACC (= 26.74)%

7. RoE 60.57%

8. Rev. Trend 20.08%

9. EPS Trend -80.29%

What is the price of LRCX shares?

As of November 29, 2025, the stock is trading at USD 156.00 with a total of 4,919,184 shares traded.
Over the past week, the price has changed by +9.36%, over one month by +0.24%, over three months by +50.17% and over the past year by +113.39%.

Is LRCX a buy, sell or hold?

Lam Research has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy LRCX.

Strong Buy: 20
Buy: 4
Hold: 9
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the LRCX price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	158.5	1.6%
Analysts Target Price	158.5	1.6%
ValueRay Target Price	219.9	41%

LRCX Fundamental Data Overview November 22, 2025

Market Cap USD = 176.03b (176.03b USD * 1.0 USD.USD)
P/E Trailing = 30.8827
P/E Forward = 30.581
P/S = 8.9848
P/B = 18.3363
P/EG = 1.8612
Beta = 1.779
Revenue TTM = 19.59b USD
EBIT TTM = 6.61b USD
EBITDA TTM = 7.01b USD
Long Term Debt = 3.73b USD (from longTermDebt, last quarter)
Short Term Debt = 754.4m USD (from shortTermDebt, last quarter)
Debt = 4.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -2.21b USD (from netDebt column, last quarter)
Enterprise Value = 173.82b USD (176.03b + Debt 4.48b - CCE 6.69b)
Interest Coverage Ratio = 49.38 (Ebit TTM 6.61b / Interest Expense TTM 134.0m)
FCF Yield = 3.36% (FCF TTM 5.85b / Enterprise Value 173.82b)
FCF Margin = 29.85% (FCF TTM 5.85b / Revenue TTM 19.59b)
Net Margin = 29.66% (Net Income TTM 5.81b / Revenue TTM 19.59b)
Gross Margin = 49.31% ((Revenue TTM 19.59b - Cost of Revenue TTM 9.93b) / Revenue TTM)
Gross Margin QoQ = 50.43% (prev 50.08%)
Tobins Q-Ratio = 7.94 (Enterprise Value 173.82b / Total Assets 21.90b)
Interest Expense / Debt = 0.02% (Interest Expense 695.0k / Debt 4.48b)
Taxrate = 15.63% (290.5m / 1.86b)
NOPAT = 5.58b (EBIT 6.61b * (1 - 15.63%))
Current Ratio = 2.21 (Total Current Assets 14.81b / Total Current Liabilities 6.71b)
Debt / Equity = 0.44 (Debt 4.48b / totalStockholderEquity, last quarter 10.19b)
Debt / EBITDA = -0.32 (Net Debt -2.21b / EBITDA 7.01b)
Debt / FCF = -0.38 (Net Debt -2.21b / FCF TTM 5.85b)
Total Stockholder Equity = 9.59b (last 4 quarters mean from totalStockholderEquity)
RoA = 26.53% (Net Income 5.81b / Total Assets 21.90b)
RoE = 60.57% (Net Income TTM 5.81b / Total Stockholder Equity 9.59b)
RoCE = 49.65% (EBIT 6.61b / Capital Employed (Equity 9.59b + L.T.Debt 3.73b))
RoIC = 39.31% (NOPAT 5.58b / Invested Capital 14.20b)
WACC = 12.56% (E(176.03b)/V(180.51b) * Re(12.88%) + D(4.48b)/V(180.51b) * Rd(0.02%) * (1-Tc(0.16)))
Discount Rate = 12.88% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.02%
[DCF Debug] Terminal Value 64.78% ; FCFE base≈5.45b ; Y1≈6.05b ; Y5≈7.93b
Fair Price DCF = 55.41 (DCF Value 69.59b / Shares Outstanding 1.26b; 5y FCF grow 12.81% → 3.0% )
EPS Correlation: -80.29 | EPS CAGR: -39.95% | SUE: 0.18 | # QB: 0
Revenue Correlation: 20.08 | Revenue CAGR: 6.35% | SUE: 2.36 | # QB: 5

Additional Sources for LRCX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle